Table of Contents
Highlights
Therapeutic Discovery
- Therapeutic DiscoveryRosa A. Carrasco, Nancy B. Stamm, Eric Marcusson, George Sandusky, Philip Iversen and Bharvin K.R. PatelMol Cancer Ther February 1 2011 10 (2) 221-232; DOI:10.1158/1535-7163.MCT-10-0756
- Therapeutic DiscoveryChristina Gruber, Iris K. Gratz, Eva M. Murauer, Elisabeth Mayr, Ulrich Koller, Leena Bruckner-Tuderman, Guerrino Meneguzzi, Helmut Hintner and Johann W. BauerMol Cancer Ther February 1 2011 10 (2) 233-241; DOI:10.1158/1535-7163.MCT-10-0669
- Therapeutic DiscoveryJeffrey J. Sutherland, Jonathan Low, Wayne Blosser, Michele Dowless, Thomas A. Engler and Louis F. StancatoMol Cancer Ther February 1 2011 10 (2) 242-254; DOI:10.1158/1535-7163.MCT-10-0720
- Therapeutic DiscoveryRakshamani Tripathi, Tanmoy Samadder, Sarika Gupta, Avadhesha Surolia and Chandrima ShahaMol Cancer Ther February 1 2011 10 (2) 255-268; DOI:10.1158/1535-7163.MCT-10-0606
- Therapeutic DiscoveryKeqiang Zhang, Jun Wu, Xiwei Wu, Xiaochen Wang, Yan Wang, Ning Zhou, Mei-ling Kuo, Xiyong Liu, Bingsen Zhou, Lufen Chang, David Ann and Yun YenMol Cancer Ther February 1 2011 10 (2) 269-278; DOI:10.1158/1535-7163.MCT-10-0728
Preclinical Development
- Preclinical DevelopmentSutapa Banerjee, Scott M. Gianino, Feng Gao, Uwe Christians and David H. GutmannMol Cancer Ther February 1 2011 10 (2) 279-291; DOI:10.1158/1535-7163.MCT-10-0654
- Preclinical DevelopmentSeema Gupta, Tulay Koru-Sengul, Susanne M. Arnold, Gayathri R. Devi, Mohammed Mohiuddin and Mansoor M. AhmedMol Cancer Ther February 1 2011 10 (2) 292-302; DOI:10.1158/1535-7163.MCT-10-0630
- Preclinical DevelopmentRouba Hage-Sleiman, Stéphanie Herveau, Eva-Laure Matera, Jean-Fabien Laurier and Charles DumontetMol Cancer Ther February 1 2011 10 (2) 303-312; DOI:10.1158/1535-7163.MCT-10-0568
- Preclinical DevelopmentJoslyn Mills, Todd Hricik, Sara Siddiqi and Igor MatushanskyMol Cancer Ther February 1 2011 10 (2) 313-324; DOI:10.1158/1535-7163.MCT-10-0724
- Preclinical DevelopmentSiân Rizzo, Jenny M. Hersey, Paul Mellor, Wei Dai, Alessandra Santos-Silva, Daniel Liber, Louisa Luk, Ian Titley, Craig P Carden, Garry Box, David L. Hudson, Stanley B. Kaye and Robert BrownMol Cancer Ther February 1 2011 10 (2) 325-335; DOI:10.1158/1535-7163.MCT-10-0788
- Preclinical DevelopmentNoriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori and John D. MinnaMol Cancer Ther February 1 2011 10 (2) 336-346; DOI:10.1158/1535-7163.MCT-10-0750
- Preclinical DevelopmentChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, Ladan Fazli, Francois Lamoureux, Eliana Beraldi, Brett P. Monia, A. Robert MacLeod, Joachim W. Thüroff and Martin E. GleaveMol Cancer Ther February 1 2011 10 (2) 347-359; DOI:10.1158/1535-7163.MCT-10-0850
- Preclinical DevelopmentTimothy A. Yap, Mike I. Walton, Lisa-Jane K. Hunter, Melanie Valenti, Alexis de Haven Brandon, Paul D. Eve, Ruth Ruddle, Simon P. Heaton, Alan Henley, Lisa Pickard, Gowri Vijayaraghavan, John J. Caldwell, Neil T. Thompson, Wynne Aherne, Florence I. Raynaud, Suzanne A. Eccles, Paul Workman, Ian Collins and Michelle D. GarrettMol Cancer Ther February 1 2011 10 (2) 360-371; DOI:10.1158/1535-7163.MCT-10-0760
February 2011
Volume 10, Issue 2
Volume 10, Issue 2
Advertisement